ALPINE IMMUNE SCIENCES, INC. Deferred Tax Assets, Valuation Allowance
ALPINE IMMUNE SCIENCES, INC. had Deferred Tax Assets, Valuation Allowance of $63.90 million as of 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2024-03-20
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $63.90M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $54.84M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $38.75M.
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $27.85M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2023-12-31 | $63.90M 10-K · filed 2024-03-20 | |
| 2022-12-31 | $54.84M 10-K · filed 2024-03-20 | |
| 2021-12-31 | $38.75M 10-K · filed 2023-03-23 | |
| 2020-12-31 | $27.85M 10-K · filed 2022-03-17 | |
| 2019-12-31 | $22.04M 10-K · filed 2021-03-18 | |
| 2018-12-31 | $13.77M 10-K · filed 2020-03-30 | |
| 2017-12-31 | $3.72M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $786.00K 10-K · filed 2018-03-28 | $39.50M 10-K · filed 2017-02-13 |
| 2015-12-31 | $22.86M 10-K · filed 2017-02-13 | |
| 2014-12-31 | $14.24M 10-K · filed 2016-03-08 |